Cleared Traditional

K213515 - WesperO2 (FDA 510(k) Clearance)

Jun 2022
Decision
220d
Days
Class 2
Risk

K213515 is an FDA 510(k) clearance for the WesperO2. This device is classified as a Oximeter (Class II - Special Controls, product code DQA).

Submitted by Wesper, Inc. (New York, US). The FDA issued a Cleared decision on June 10, 2022, 220 days after receiving the submission on November 2, 2021.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 870.2700.

Submission Details

510(k) Number K213515 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 2021
Decision Date June 10, 2022
Days to Decision 220 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code DQA - Oximeter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2700